Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Tech Coloproctol ; 28(1): 77, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38954131

ABSTRACT

BACKGROUND: Bladder drainage is systematically used in rectal cancer surgery; however, the optimal type of drainage, transurethral catheterization (TUC) or suprapubic catheterization (SPC), is still controversial. The aim was to compare the rates of urinary tract infection on the fourth postoperative day (POD4) between TUC and SPC, after rectal cancer surgery regardless of the day of removal of the urinary drain. METHODS: This randomized clinical trial in 19 expert colorectal surgery centers in France and Belgium was performed between October 2016 and October 2019 and included 240 men (with normal or subnormal voiding function) undergoing mesorectal excision with low anastomosis for rectal cancer. Patients were followed at postoperative days 4, 30, and 180. RESULTS: In 208 patients (median age 66 years [IQR 58-71]) randomized to TUC (n = 99) or SPC (n = 109), the rate of urinary infection at POD4 was not significantly different whatever the type of drainage (11/99 (11.1%) vs. 8/109 (7.3%), 95% CI, - 4.2% to 11.7%; p = 0.35). There was significantly more pyuria in the TUC group (79/99 (79.0%) vs. (60/109 (60.9%), 95% CI, 5.7-30.0%; p = 0.004). No difference in bacteriuria was observed between the groups. Patients in the TUC group had a shorter duration of catheterization (median 4 [2-5] vs. 4 [3-5] days; p = 0.002). Drainage complications were more frequent in the SPC group at all followup visits. CONCLUSIONS: TUC should be preferred over SPC in male patients undergoing surgery for mid and/or lower rectal cancers, owing to the lower rate of complications and shorter duration of catheterization. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02922647.


Subject(s)
Drainage , Postoperative Complications , Rectal Neoplasms , Urinary Catheterization , Urinary Tract Infections , Humans , Male , Rectal Neoplasms/surgery , Middle Aged , Aged , Urinary Catheterization/methods , Urinary Catheterization/adverse effects , Drainage/methods , Urinary Tract Infections/etiology , Urinary Tract Infections/prevention & control , Urinary Tract Infections/epidemiology , Postoperative Complications/etiology , Postoperative Complications/epidemiology , Urinary Bladder/surgery , Belgium
2.
Arch Pediatr ; 28(2): 141-146, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33334653

ABSTRACT

BACKGROUND: This study aimed to assess how the emergence of high-flow nasal cannula (HFNC) has modified the demographic and clinical characteristics as well as outcomes of infants with bronchiolitis admitted to a pediatric intensive care unit (PICU). METHODS: This was a single-center retrospective study including infants aged 1 day to 6 months with bronchiolitis requiring HFNC, noninvasive ventilation (NIV), or invasive ventilation on admission. RESULTS: A total of 252 infants (mean age 53±36 days) were included in the study. The use of HFNC increased from 18 (21.4%) during 2013-2014 to 53 infants (55.2%) during 2015-2016. The length of stay in the PICU decreased over time from 4.7±2.9 to 3.5±2.7 days (P<0.01) but the hospital length of stay remained similar (P=0.17). On admission, patients supported by HFNC as the first-line therapy were older. The PICU length of stay was similar according to the type of respiratory support (P=0.16), but the hospital length of stay was longer for patients supported by HFNC (P=0.01). CONCLUSION: The distribution of respiratory support has significantly changed over time for patients with bronchiolitis and HFNC is increasingly used. The demographic and clinical characteristics of the have not changed over time. However, the PICU length of stay decreased significantly.


Subject(s)
Bronchiolitis/therapy , Critical Care/methods , Intensive Care Units, Pediatric , Oxygen Inhalation Therapy/methods , Practice Patterns, Physicians'/trends , Bronchiolitis/diagnosis , Cannula , Critical Care/trends , Female , Humans , Infant , Infant, Newborn , Length of Stay/trends , Male , Oxygen Inhalation Therapy/instrumentation , Oxygen Inhalation Therapy/trends , Respiration, Artificial/methods , Respiration, Artificial/trends , Retrospective Studies , Treatment Outcome
3.
J Viral Hepat ; 25(2): 171-179, 2018 02.
Article in English | MEDLINE | ID: mdl-28984055

ABSTRACT

Liver steatosis is common in human immunodeficiency virus (HIV)-hepatitis C virus (HCV)-co-infected patients. Some recent studies have found that cannabis use is negatively associated with insulin resistance in the general population and in HIV-HCV-co-infected patients. Given the causal link between insulin resistance and steatosis, we hypothesized that cannabis use has a positive impact on steatosis. Therefore, we aimed to study whether cannabis use in this population was associated with a reduced risk of steatosis, measured by ultrasound examination. ANRS CO13-HEPAVIH is a French nationwide multicentre cohort of HIV-HCV-co-infected patients. Medical and socio-behavioural data from clinical follow-up visits and annual self-administered questionnaires were prospectively collected. A cross-sectional analysis was conducted using data from the first visit where both ultrasound examination data for steatosis (positive or negative diagnosis) and data on cannabis use were available. A logistic regression model was used to evaluate the association between cannabis use and steatosis. Among study sample patients (n = 838), 40.1% had steatosis. Fourteen per cent reported daily cannabis use, 11.7% regular use and 74.7% no use or occasional use ("never or sometimes"). Daily cannabis use was independently associated with a reduced prevalence of steatosis (adjusted odds ratio [95% CI] = 0.64 [0.42;0.99]; P = .046), after adjusting for body mass index, hazardous alcohol consumption and current or lifetime use of lamivudine/zidovudine. Daily cannabis use may be a protective factor against steatosis in HIV-HCV-co-infected patients. These findings confirm the need for a clinical evaluation of cannabis-based pharmacotherapies in this population. Eudract.ema.europa.eu number, DGS050367.


Subject(s)
Coinfection/virology , Fatty Liver/epidemiology , HIV Infections/complications , Hepatitis C/complications , Marijuana Smoking/adverse effects , Adult , Coinfection/complications , Cross-Sectional Studies , Fatty Liver/diagnostic imaging , Fatty Liver/virology , Female , France/epidemiology , HIV Infections/virology , Hepacivirus/drug effects , Hepatitis C/virology , Humans , Insulin Resistance , Liver/diagnostic imaging , Liver/pathology , Logistic Models , Male , Marijuana Smoking/epidemiology , Middle Aged , Prospective Studies , Risk Factors , Surveys and Questionnaires , Ultrasonography/methods
4.
AIDS Care ; 28(11): 1345-54, 2016 11.
Article in English | MEDLINE | ID: mdl-27267205

ABSTRACT

HAART has improved the well-being of many people living with HIV (PLWH). This study aimed at (i) comparing heterosexual practices between PLWH and the general population by gender, and (ii) identifying factors associated with sexual practices and at-risk behaviors in the two populations. Self-reported data were collected among PLWH attending hospitals (VESPA2 survey; n = 3022) and the general population (CSF survey; n = 10,280). Significant differences between the two samples were corrected for by implementing propensity score matching on both socio-demographic characteristics and sexual behavior in terms of number of partners. Men not reporting heterosexual intercourse were excluded. After matching, 61% of women (out of 707) and 68% of men (out of 709) were sexually active in both populations. PLWH practiced oral sex less than the general population and used condoms more consistently over the previous 12-month period, irrespective of having multiple sexual partners or not. For women living with HIV: those with several sexual partners and those consuming drugs over the previous 12 months were more likely to practice oral sex; those living in a couple for at least 6 years and migrants were less likely to practice anal intercourse. For men living with HIV: those reporting bisexual relationships and those with multiple sexual partners over the previous 12 months were more likely to practice anal heterosexual intercourse; migrants reported less oral sex, irrespective of HIV status. Error term correlations showed that anal intercourse was not linked to condom use for women or men from either population. Our results show that PLWH had a lower rate of heterosexual practices compared with the general population, and used condoms more often, irrespective of the number of sexual partners and strong cultural background (e.g., for Sub-Saharan African women). Further preventive information needs to be disseminated on the risk of infection transmission through heterosexual anal intercourse.


Subject(s)
Condoms/statistics & numerical data , HIV Infections , Heterosexuality/statistics & numerical data , Adolescent , Adult , Bisexuality , Case-Control Studies , Female , France , HIV Infections/prevention & control , HIV Infections/psychology , Heterosexuality/ethnology , Humans , Male , Middle Aged , Risk-Taking , Sex Factors , Sexual Partners , Surveys and Questionnaires , Transients and Migrants/statistics & numerical data , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...